Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-02-14
2010-06-08
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S597000, C530S350000, C530S384000
Reexamination Certificate
active
07732405
ABSTRACT:
The present invention is directed to liquid, aqueous pharmaceutical compositions stabilized against chemical and/or physical degradation containing Factor VII polypeptides, and methods for preparing and using such compositions, as well as vials containing such compositions, and the use of such compositions in the treatment of a Factor VII-responsive syndrome. The main embodiment is represented by a liquid, aqueous pharmaceutical composition comprising at least 0.01 mg/mL of a Factor VII polypeptide (i); a buffering agent (ii) suitable for keeping pH in the range of from about 4.0 to about 9.0; and at least one stabilizing agent (iii) comprising a —C(═N-Z1-R1)—NH-Z2-R2motif, e.g. benzamidine compounds and guanidine compounds such as arginine.
REFERENCES:
patent: 5399670 (1995-03-01), Bhattacharya et al.
patent: 5457181 (1995-10-01), Michalski et al.
patent: 6310183 (2001-10-01), Johannessen et al.
patent: 6586573 (2003-07-01), Besman et al.
patent: 6586574 (2003-07-01), Hansen
patent: 2002/0110552 (2002-08-01), Romisch et al.
patent: 2003/0109446 (2003-06-01), Rojkjaer
patent: 2004/0037893 (2004-02-01), Hansen et al.
patent: 2006/0063714 (2006-03-01), Jensen et al.
patent: 19853033 (1998-11-01), None
patent: 225160 (1987-06-01), None
patent: 430200 (1989-11-01), None
patent: 952215 (1999-02-01), None
patent: 336548 (2001-08-01), None
patent: 01/58935 (2001-08-01), None
patent: 01/82943 (2001-11-01), None
patent: 01/85198 (2001-11-01), None
patent: WO 03/055512 (2003-07-01), None
patent: 2004/082708 (2004-09-01), None
patent: 2004/110469 (2004-12-01), None
Cleland M.C. et al., Pharm Res, vol. 6(11), pp. 903-918 (1989).
Manning, J.L. et al., Crit Rev In Thera Drug Carr Sys., vol. 10(4), pp. 307-377 (1993).
Sichler, K. et al., J Mol Biol., vol. 322(3), pp. 591-603 (2002).
Wang et al., J Parenter Sci Technol., vol. 42(10), pp. 4-26 (1988).
Bowler Andrew Neil
Jensen Michael Bech
Petersen Anders Klarskov
Kam Chih-Min
Novo Nordisk Health Care AG
Walker Shelby J.
LandOfFree
Liquid, aqueous pharmaceutical compositions of factor VII... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liquid, aqueous pharmaceutical compositions of factor VII..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid, aqueous pharmaceutical compositions of factor VII... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4188818